Structure determination and refinement. All X-ray diffraction data were collected at 100 K using a cryostream apparatus with synchrotron radiation at the IMCA-CAT beam line 17 Number DE-AC02-98CH10886. All diffraction data were processed with HKL2000 (2) . The crystals belong to space group P42 1 2 (Table S1) , with six molecules per asymmetric unit, and have a V m of 4.97 Å 3 /Da (solvent content of ≈75%). Experimental phase information was derived from a single anomalous dispersion (SAD) diffraction experiment using a selenomethioninesubstituted FLAP crystal in complex with the iodinated analog of MK-591 that was measured at the wavelength corresponding to the peak of the selenium X-ray fluorescence spectrum (3).
Eighteen selenium sites were located and refined with SHARP (4). The hand of the molecule was established by unambiguous differences observed in experimental electron density maps calculated from both phases of the heavy atom enantiomorphs (Fig. S2) . The selenium sites were used to define the three-fold rotational symmetry of the trimer as well as the relationship between the two trimers in the asymmetric unit with Professs. We also observed six additional peaks in the anomalous difference map that could not be associated with protein-related features (Fig. S3A ).
We concluded that these peaks arose from the iodine atom in this inhibitor based on the following observations. Given that this diffraction data was collected at the peak of the selenium X-ray fluorescence spectrum, iodine has a limited anomalous signal at this wavelength (theoretical anomalous scattering values of f' ≈0 and f" ≈3). The relative peak heights of these six anomalous peaks when compared to the 18 selenium sites are consistent with them corresponding to iodine atoms. The experimental electron density surrounding these six anomalous peaks also showed the expected features for this iodinated inhibitor (Fig. S3A) . Addition of the iodine atoms to experimental phase refinement had a minimal effect on the refinement statistics and map quality, presumably due to the weak phasing power of iodine anomalous scattering at this wavelength.
The experimental electron density map was initially improved with SOLOMON and DM using a solvent fraction of ≈75%. The helix building module of ARP/wARP within SHARP (4) (5) (6) (7) was then used to automatically build two distinct helical bundles into the experimental electron density map, which represents approximately 40% of the expected contents of the asymmetric unit. Those regions that could be automatically built with helices composed of alanine residues form the lipid-embedded regions of the transmembrane helices. No continuous segments of the FLAP sequence could be automatically fit into the experimental electron density map by ARP/wARP using experimental phases. The clarity of the experimental electron density map was further improved by iterative six-fold NCS averaging and B-factor sharpening ( Macromolecular refinement utilized all reflection data and Hendrickson-Lattman coefficients, and was carried out using the BUSTER-GELLY-TNT software package from Global Phasing (9) . Rigid body refinement was used to (1) optimize the relative positions of the four transmembrane helices that compose each FLAP monomer; (2) position the six copies of the FLAP monomer that are found in the asymmetric unit; and (3) establish the orientations of the two closely packed trimers that are found in the asymmetric unit. It should be noted that it is not possible to interpret this packing arrangement as a biologically relevant dimer-of-trimers as both trimers are positioned essentially perpendicular to each other. Six-fold NCS restraints (main chain and side chain atoms only) were applied to all residues during the early stages of refinement.
Geometrical constraints on these inhibitors were used throughout refinement. Once the protein sequence had been assigned, NCS restraints were released from the lumenal helix, cytosolic loops C1 and C2, lumenal loop L1, and all residues beyond residue G140. Although this partial release of NCS restraints results in distinct conformations for both cytosolic loops, the conformations and relative positions of the lumenal helices and loops remain unchanged. We also observed a drop in R free at this stage of the refinement. During the later stages of refinement, only partial NCS restraints (main chain atoms only) were maintained on the transmembrane helices (residues 11-37, 44-77, 80-101 and 116-140), and application of this NCS restraint scheme produced an additional drop in R free . Given the relatively modest resolution of this data we choose not to continue with additional rounds of refinement without NCS restraints. In control experiments, however, we did remove all NCS restraints and found that the model remained substantially unchanged and that there was no sharp increase in R free . Split main chain and side chain B-factor refinement was used at the final stage of refinement, resulting in a marginal drop in the overall R free value (8) showed connected difference density in the membrane-embedded inhibitor binding site, and this volunteer electron density had the expected molecular features of MK-591 (Fig. S4) . The final models for FLAP in complex with these inhibitors contain all residues except for approximately twenty C-terminal residues, and they have reasonable geometry (Fig. S5, A and B) . Bond lengths and angles are not distorted and the protein main chain has reasonable angles, with ≈80% of residues in the accepted regions of the Ramachandran plot, and most of the remaining ≈20% of residues falling within the generously allowed regions.
As in all low resolution crystallography, there is a danger of over refinement in these studies. With NCS, the data-to-parameter ratio is 4.14 (20,007 unique reflections / 1,209 atoms).
This ratio is an inescapable consequence of the diffraction limit of this crystal form. Given this fact, we carefully applied rigorous validation tests to our model. Confidence in the model comes Supporting Online Materialfrom the observations that (1) electron density for many side chains is apparent in the unbiased experimental SAD electron density maps; (2) appropriate volunteer electron density for inhibitor MK-591 arises from molecular replacement phases using only the protein component of the FLAP-iodinated inhibitor complex; (3) minimum R free values occur when NCS restraints are applied only to the main chain atoms of the transmembrane helices, a restraint scheme consistent with expected topology of integral membrane proteins; (4) volunteer electron density for the lumenal helices as well as cytosolic and lumenal loops appear in electron maps where the conformation of those features has not been restrained; (5) there is volunteer electron density with the appropriate molecular features and location for detergent and/or lipid molecules; and (6) electron density supporting the model arises in omit maps.
Radioligand binding assay.
Competitive radioligand binding assays were performed as previously described (10, 11) . a Values for the highest resolution shell are shown in parentheses.
, where I hkl is the integrated intensity of the given reflection. c Phasing power, ∑ | F H | / ∑ | E |, was calculated using SHARP (13) .
where F o and F c are observed and calculated structure factors. e Five percent of the data were omitted from the refinement to calculate R free (14) . Western blotting was used to demonstrate that equal amounts of protein are expressed for these directed mutants (data not shown). All residues found within 4 Å of the bound iodinated structural analog of MK-591 belong to Group 1. Those residues positioned greater than 4 Å from the inhibitor molecule belong to Group 2. (11, (15) (16) (17) Fig. S1. Structural comparison between the X-ray crystal structure of human FLAP and electron microscopy structure of rat mGST-1. (A-C) 90° rotations within the plane of the membrane. Right panel -FLAP. Center panel -mGST-1. Right panel -Structural superposition of FLAP (green) and mGST-1 (purple). The coordinates were structurally aligned to those of mGST-1 (PDB code: 2H8A) using the program DALI Lite (18) (Z-score of 9.1, 107 aligned residues, RMSD of 3.1 Å and 10% sequence identity). The density modified and sixfold NCS-averaged experimental SAD electron density map for FLAP in complex with the iodinated analog of MK-591 (contoured at 1σ) is shown as blue mesh. In these panels, the view is given from the cytosol. The FLAP trimer is shown with monomers colored green, cyan and magenta, respectively. The inhibitor molecule is shown as a stick model with yellow carbon atoms, blue nitrogen atoms, red oxygen atoms and purple iodine atoms. 
